Back to News
Market Impact: 0.6

Exact Sciences (EXAS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

EXASAPLS
Corporate EarningsAnalyst EstimatesAnalyst InsightsCompany FundamentalsHealthcare & BiotechCorporate Guidance & OutlookInvestor Sentiment & Positioning
Exact Sciences (EXAS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Exact Sciences (EXAS) is anticipated to report strong results for its upcoming quarter, with consensus estimates projecting a 147.6% year-over-year EPS increase to $0.10 and 14.3% revenue growth to $809.93 million. The company demonstrates a high probability of exceeding these consensus estimates, driven by a positive Zacks Earnings ESP of +56.25% and a Zacks Rank #1, positioning it as a compelling earnings-beat candidate for institutional investors.

Analysis

Exact Sciences (EXAS) is anticipated to report robust results for the quarter ended September 2025, with consensus estimates projecting a significant year-over-year EPS increase of 147.6% to $0.10 per share and revenue growth of 14.3% to $809.93 million. Analyst sentiment has been increasingly bullish, evidenced by a 9.76% upward revision in the consensus EPS estimate over the past 30 days, suggesting improving business conditions and heightened confidence among covering analysts. The company exhibits a high probability of exceeding these consensus estimates, supported by a strong Zacks Earnings ESP of +56.25% and a Zacks Rank #1 (Strong Buy). This combination historically predicts an earnings beat nearly 70% of the time, indicating that the Most Accurate Estimate is significantly higher than the consensus. Furthermore, Exact Sciences has a strong track record, having surpassed EPS estimates in three of the last four quarters, including a substantial 1,200% surprise in the previous quarter. This strong earnings outlook, coupled with positive analyst revisions and a high probability of an earnings beat, positions EXAS as a compelling candidate for potential positive stock price movement post-announcement on November 3. While an earnings beat does not guarantee stock appreciation, the confluence of these positive indicators suggests favorable investor sentiment leading into the release.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.